Prevention of ovariectomy-induced osteoporosis in rats

The effects of sclerostin antibody plus parathyroid hormone (1–34) on bone formation in ovariectomized rats

(2017) Jian Wu et al.   ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE

New horizons in treatment of osteoporosis

(2017) Ozra Tabatabaei-Malazy et al.   DARU-Journal of Pharmaceutical Sciences

The Effect of Vibration Treatments Combined with Teriparatide or Strontium Ranelate on Bone Healing and Muscle in Ovariectomized Rats

(2016) M. Komrakova et al.   CALCIFIED TISSUE INTERNATIONAL

Treatment study of distal femur for parathyroid hormone (1–34) and β-tricalcium phosphate on bone formation in critical size defects in rats

(2015) Zhou-Shan Tao et al.   JOURNAL OF BIOMATERIALS APPLICATIONS

Combined treatment with parathyroid hormone (1–34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model

(2015) Zhou-Shan Tao et al.   MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING

Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats

(2013) B. Chen et al.   OSTEOPOROSIS INTERNATIONAL

Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus

(2012) Christine Hamann et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Vitamin K2 Improves Renal Function and Increases Femoral Bone Strength in Rats with Renal Insufficiency

(2011) Jun Iwamoto et al.   CALCIFIED TISSUE INTERNATIONAL

The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats

(2011) Y. F. Li et al.   OSTEOPOROSIS INTERNATIONAL

Stem Cells and Osteoporosis Therapy

(2010) Steven L. Teitelbaum   Cell Stem Cell

Risedronate Directly Inhibits Osteoclast Differentiation and Inflammatory Bone Loss

(2009) Han Bok Kwak et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Osteoblasts play key roles in the mechanisms of action of strontium ranelate

(2009) TC Brennan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Strontium Ranelate Enhances Callus Strength More Than PTH 1-34 in an Osteoporotic Rat Model of Fracture Healing

(2009) Bjoern Habermann et al.   CALCIFIED TISSUE INTERNATIONAL

Bisphosphonates: Mechanism of Action and Role in Clinical Practice

(2009) Matthew T. Drake et al.   MAYO CLINIC PROCEEDINGS

Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms

(2008) Joseph Caverzasio   BONE

Longitudinalin VivoAnalysis of the Region-Specific Efficacy of Parathyroid Hormone in a Rat Cortical Defect Model

(2008) David E. Komatsu et al.   ENDOCRINOLOGY

Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response

(2008) G. J. Atkins et al.   OSTEOPOROSIS INTERNATIONAL

Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants

(2008) S. D. Bain et al.   OSTEOPOROSIS INTERNATIONAL

Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats

(2007) Koji Nozaka et al.   BONE

Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro

(2007) Edith Bonnelye et al.   BONE